News | June 24, 2013

Emory Proton Therapy Center Breaks Ground in Atlanta

Emory Proton Therapy Center Breaks Ground Atlanta

June 24, 2013 — A new first for Georgia was celebrated Thursday, May 2, as Emory Healthcare and the Winship Cancer Institute broke ground on the new Emory Proton Therapy Center. Brasfield & Gorrie, the general contractor on the more than $200 million dollar oncology center, was joined in the celebration by developer Advanced Particle Therapy and elected officials, including Atlanta Mayor Kasim Reed.

In his remarks, Mayor Reed addressed the center’s impact, not only on the lives of patients but also on the city’s economic and research development.

Located in downtown Atlanta at the corner of Peachtree Street and North Avenue, the 107,000 square foot center will accommodate approximately 2,200 cancer patients each year. The facility will open its doors to patients in 2016 after an 18-month commissioning period for the Varian Medical Systems equipment.

The new proton treatment facility will incorporate several unique features, including the 16-foot-thickspecialized shielding walls necessary to house pencil beam scanning equipment. To date, only one proton therapy center in the nation offers pencil beam scanning capabilities and in only one room. The Emory Proton Therapy Center will feature this advanced capability in all five of its treatment rooms.

Under the direction of developer Advanced Particle Therapy, Brasfield & Gorrie is working with Signet Development, Emory Healthcare, VOA Associates and Perkins+Will.

“This facility represents a wonderful opportunity to fulfill a health care need for the people of Georgia and surrounding states. We look forward to a successful building process and turning over a treatment center that will improve the lives of many patients,” said Trey Sanders, regional president of Brasfield & Gorrie.

For more information:

Related Content

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Overlay Init